UroLase: Ablación transuretral con láser para tumores de vejiga

UroLase: Ablación transuretral con láser para tumores de vejiga

Ablación transuretral con láser para tumores de vejiga: Un sistema láser de última generación diseñado para la ablación precisa de tumores de vejiga a través de la uretra, que ofrece una invasividad mínima, una hemorragia reducida y una mayor precisión para la extirpación eficaz del tumor.

Información

UroLase is an advanced laser ablation platform tailored for trans-urethral treatment of bladder tumors. By harnessing high-energy laser beams, UroLase allows precise destruction or resection of superficial malignant lesions with minimal bleeding and faster recovery times compared to conventional electrocautery methods. Whether employed for initial tumor debulking or repeated interventions in recurrent cases, UroLase’s laser technology delivers efficient, targeted therapy in a wide array of clinical scenarios.

High-Energy Laser Fiber
  • Targeted Ablation: Generates intense energy at the lesion interface, vaporizing or resecting tumor tissue with reduced thermal damage to adjacent structures.
  • Precise Beam Control: Allows fine control of ablation depth, particularly beneficial in delicate bladder anatomy.
  • Endoscopic Guidance: UroLase can be introduced through standard rigid or flexible cystoscopes, ensuring direct visualization of tumor margins.
  • Outpatient Potential: Many superficial bladder tumor cases can be managed in a less invasive, outpatient setup, shortening hospital stays.
  • Ergonomic Laser Console: Often integrates with known endoscopic or imaging equipment, simplifying the operator’s workflow.
  • Versatile Fiber Tips: Customized lengths or tip types are available to adapt to different lesion locations—e.g., bladder trigone, lateral walls.

Características principales

Efficient Tissue Ablation
  • Rapid Vaporization: Concentrated laser energy sears tumor tissue quickly, enabling swift tumor reduction.
  • Hemostatic Effect: Laser coagulates small vessels as it ablates, reducing bleeding compared to mechanical resection.
  • Adjustable Laser Parameters: Power, pulse duration, and frequency can be tuned to meet the specific demands of tumor size, location, or histology.
  • Real-Time Endoscopic Monitoring: The physician can gauge the extent of ablation or potential residual tumor in the same session.
  • Focused Beam: Minimizes thermal spread beyond the intended ablation zone, preserving healthy bladder mucosa.
  • Tissue-Sparing: Reduces resection depth, beneficial for sensitive areas (e.g., near the ureteric orifices or around the bladder neck).
  • Potentially Outpatient: Many tumors can be treated with minimal anesthesia requirements, alleviating patient stress and saving resources.
  • Speedy Recovery: Less postoperative discomfort and fewer catheterization days compared to traditional approaches.

Clinical Advantages

Wide Range of Tumor Profiles
  • Superficial Tumors: Highly effective for non-muscle-invasive lesions, including Ta, T1, and some CIS (carcinoma in situ).
  • Recurrent Disease: Provides an option for repeat interventions without extensive impact on bladder integrity.
  • Decreased Bleeding: Laser ablation’s inherent coagulation effect promotes clearer visualization and less transfusion necessity.
  • Potentially Less Pain: Gentle approach and controlled ablation help mitigate postoperative discomfort.
  • Preserves Bladder Function: Minimally disruptive technique doesn’t compromise subsequent treatments, e.g., intravesical therapies or partial cystectomy if needed.
  • Compatible with Adjunct Therapies: Combines easily with TURBT (Transurethral Resection of Bladder Tumor) or immune checkpoint therapies in more advanced or high-risk cases.

Productos relacionados